Abstract
Methotrexate dose-escalation studies in transgenic mice and marrow transplant recipients expressing drug-resistant dihydrofolate reductase activity.
C May, R I James, R Gunther and R S McIvor
Journal of Pharmacology and Experimental Therapeutics September 1996, 278 (3) 1444-1451;